Exhibits and Sponsorship
Corporate Partners
For the American Headache Society’s corporate partners, The Scottsdale Headache Symposium® continues to be a successful venue for providing practical, clinical, evidence-based information on the diagnosis, management, and treatment of headache patients. Education is presented in didactic, case-based, evidence-based, panel, and demonstrative formats
The meeting presents a unique opportunity for collaboration. We recognize the significant role the contributions of our corporate partners play in ensuring the success of this event.
Exhibit Hall Floorplan/Exhibitor List
Click here to access the live floorplan and see the list of 2023 exhibitors.
Exhibit Hours*
Set-Up Hours
Wednesday, November 15, 8:00 AM – 8:00 PM
Thursday, November 16, 7:00 AM – 3:00 PM
Show Floor Hours
Thursday, November 16: 5:00 PM – 6:00 PM (Exhibit/Welcome Reception)
Friday, November 17: 7:00 AM – 8:00 AM / 10:20 AM – 10:45 AM / 12:30 PM – 1:30 PM / 5:00 PM – 6:00 PM (HAPPY HOUR)
Saturday, November 18: 7:00 AM – 8:00 AM / 10:00 AM – 10:30 AM / 12:30 PM – 2:00 PM
Strike Hours
Saturday, November 18, 2:30 PM – 7:30 PM
Acknowledgements
The American Headache Society gratefully acknowledges the support of the 2023 Scottsdale Headache Symposium from our industry supporters:
PLATINUM
We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit lilly.com and lilly.com/newsroom or follow us on Facebook, Instagram, and LinkedIn.
Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, is tirelessly dedicated to restoring brain health, so every person can be their best. Lundbeck has a long heritage of innovation in neuroscience and is focused on delivering transformative treatments that address unmet needs in brain health.
Breakthroughs That Change Patients’ Lives. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
GOLD
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
SILVER
PRESENTING
The American Headache Society gratefully acknowledges the educational grant support of the 2023 Scottsdale Headache Symposium from our industry supporters:
Eli Lilly and Company
Lundbeck Pharmaceuticals, LLC
Pfizer, Inc.
The American Headache Society gratefully acknowledges the educational grant support of the Cadaver Course from our industry supporter:
Eli Lilly and Company
The American Headache Society gratefully acknowledges the educational grant support and in-kind donation of migraine units (heads) for the Injection Training Workshop from our industry supporter:
AbbVie, Inc.
The American Headache Society gratefully acknowledges the educational grant support of the Launchpad to Headache Essentials Course from our industry supporter:
AbbVie, Inc.
Eli Lilly and Company
Questions
Please contact AHS Headquarters if you have questions about sponsoring or exhibiting. Sponsor and Exhibit contact: Darryl Diamond (ddiamond@talley.com).